Efficacy of High-Dose Methotrexate in Pediatric Non-Infectious Uveitis

REFERENCES

• Mehta PJ, Alexander JL, Sen HN. Pediatric uveitis: new and future treatments. Curr Opin Ophthalmol. 2013;24(5):453–462. doi:10.1097/ICU.0b013e3283641ede.
   PubMed Web of Science ®Google Scholar
• Sauberan DP. Pediatric uveitis. Int Ophthalmol Clin. 2010;50(4):73–85. doi:10.1097/IIO.0b013e3181f0f2b5.
   PubMedGoogle Scholar
• de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879–884.
   PubMed Web of Science ®Google Scholar
• Wentworth BA, Freitas-Neto CA, Foster CS. Management of pediatric uveitis. F1000Prime Rep. 2014;6:41. eCollection 2014. doi:10.12703/P6-41.
   PubMedGoogle Scholar
• Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111(12):2299–2306. doi:10.1016/j.ophtha.2004.06.014.
   PubMed Web of Science ®Google Scholar
• Gregory AC 2nd, Kempen JH, Daniel E, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study. Ophthalmology. 2013;120(1):186–192. doi:10.1016/j.ophtha.2012.07.052.
   PubMed Web of Science ®Google Scholar
• Wong VG. Methotrexate treatment of uveal disease. Am J Med Sci. 1966;251:239–241.
   PubMed Web of Science ®Google Scholar
• Simonini G, Paudyal P, Jones GT, Cimaz R, Macfarlane GJ. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology (Oxford). 2013;52(5):825–831. doi:10.1093/rheumatology/kes186.
   PubMed Web of Science ®Google Scholar
• Visser K. van der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis. 2009;68(7):1094–1099. doi:10.1136/ard.2008.092668.
   PubMed Web of Science ®Google Scholar
• Chan ES, Cronstein BN. Methotrexate–how does it really work? Nat Rev Rheumatol. 2010;6(3):175–178. doi:10.1038/nrrheum.2010.5.
   PubMed Web of Science ®Google Scholar
• Hashkes PJ, Becker ML, Cabral DA, et al. Methotrexate: new uses for an old drug. J Pediatr. 2014;164(2):231–236. doi:10.1016/j.jpeds.2013.10.029.
   PubMed Web of Science ®Google Scholar
• Ruperto N, Murray KJ, Gerloni V, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 2004;50(7):2191–2201. doi:10.1002/art.20288.
   PubMed Web of Science ®Google Scholar
• Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E initiative. Ann Rheum Dis. 2009;68(7):1086–1093. doi:10.1136/ard.2008.094474.
   PubMed Web of Science ®Google Scholar
• Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(8):1544–51, 1551.e1. doi:10.1016/j.ophtha.2009.05.002.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton, 2001. J Rheumatol. 2004;31:390–392.
   PubMed Web of Science ®Google Scholar
• El Edelbi R, Lindemalm S, Eksborg S. Estimation of body surface area in various childhood ages–validation of the mosteller formula. Acta Paediatr. 2012;101(5):540–544. doi:10.1111/j.1651-2227.2011.02580.x.
   PubMed Web of Science ®Google Scholar
• Sharma SM1, Ad D, Ramanan AV. Non-infectious pediatric uveitis: an update on immunomodulatory management. Paediatr Drugs. 2009;11:229–241.
   PubMedGoogle Scholar
• van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann Rheum Dis. 2015;74(5):806–812. doi:10.1136/annrheumdis-2014-206047.
   PubMed Web of Science ®Google Scholar
• van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis. 2014;73(5):861–870. doi:10.1136/annrheumdis-2012-203130.
   PubMed Web of Science ®Google Scholar
• Wallace CA, Giannini EH, Spalding SJ, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012;64(6):2012–2021. doi:10.1002/art.34343.
   PubMed Web of Science ®Google Scholar
• Magnani A, Pistorio A, Magni-Manzoni S, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:628–634. doi:10.3899/jrheum.080560.
   PubMed Web of Science ®Google Scholar
• Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242–1248.
   PubMed Web of Science ®Google Scholar
• van Dijkhuizen EH, Wulffraat NM. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: A systematic literature review. Pediatr Rheumatol Online J. 2014;12:51–0096-12–51. eCollection 2014. doi:10.1186/1546-0096-12-51.
   PubMed Web of Science ®Google Scholar
• van Dijkhuizen EH, Bulatovic Calasan M, Pluijm SM, et al. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study. Pediatr Rheumatol Online J. 2015;13:5–015-0002–3. eCollection 2015. doi:10.1186/s12969-015-0002-3.
   PubMed Web of Science ®Google Scholar
• Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol. 2005;89(7):806–808. doi:10.1136/bjo.2004.054239.
   PubMed Web of Science ®Google Scholar
• Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2005;32:362–365.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Mingels A, Heinz C, Ganser G. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol. 2007;17:743–748.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. 2011;151(2):217–222. doi:10.1016/j.ajo.2010.08.021.
   PubMed Web of Science ®Google Scholar
• Hoffmeister RT. Methotrexate in rheumatoid arthritis (abstract). Arthritis Rheumatol. 1972;15:114.
   Google Scholar
• Hoffmeister RT. Methotrexate therapy in rheumatoid arthritis: 15 years’ experience. Am J Med. 1983;(75):69–73. doi:10.1016/0002-9343(83)90477-1.
   PubMedGoogle Scholar
• Willkens RF, Watson MA, Paxson CS. Low dose pulse methotrexate therapy in rheumatoid arthritis. J Rheumatol. 1980;7:501–505.
   PubMedGoogle Scholar
• Willkens RF, Watson MA. Methotrexate: a perspective of its use in the treatment of rheumatic diseases. J Lab Clin Med. 1982;100:314–321.
   PubMed Web of Science ®Google Scholar
• Tuková J, Chládek J, Nemcová D, Chládková J, Dolezalová P. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis. Clin Exp Rheumatol. Nov-Dec 2009;27(6):1047–1053.
   PubMed Web of Science ®Google Scholar
• Braun J. Optimal administration and dosage of methotrexate. Clin Exp Rheumatol. 2010 Sep-Oct;28(5Suppl 61):S46–51. Epub 2010 Oct 28.
   PubMedGoogle Scholar
• Bello AE, Perkins EL, Jay R, Efthimiou P. Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis. Open Access Rheumatol. 2017 Mar 31;9:67–79. doi:10.2147/OARRR.S131668.
   PubMed Web of Science ®Google Scholar